GR2 Lung Cancer Grand Round

Grand round
Chairs: Nir Peled (Hod Hasharon, IL), Paul E. Van Schil (Edegem (Antwerp), BE), Paul Martin Putora (St. Gallen, CH), Claus Peter Heussel (Heidelberg, DE)

Benign or malignant ? - a tricky solitary pulmonary nodule in a patient at high risk for lung cancer Mina Gaga (Athens, Greece)
Pushing the limits, real benefit for the patient ? – a curative treatment approach in an unfit lung cancer patient Matthew Evison (Manchester, United Kingdom)
Eminence or evidence based ? – personalised diagnostic-therapeutic sequences in a molecular altered advanced NSCLC patient Nir Peled (Hod Hasharon, Israel)